Clinical Trials Directory

Trials / Conditions / Myelodysplastic Syndrome With Excess Blasts-1

Myelodysplastic Syndrome With Excess Blasts-1

7 registered clinical trials studyying Myelodysplastic Syndrome With Excess Blasts-1 — 2 currently recruiting.

StatusTrialSponsorPhase
UnknownEvaluate the Efficacy and Safety of Allogeneic Haematopoietic Stem Cell Transplantation With FBM Conditioning
NCT06247917
Ruijin HospitalPhase 2
RecruitingAllo HSCT Using RIC and PTCy for Hematological Diseases
NCT05805605
Masonic Cancer Center, University of MinnesotaPhase 2
RecruitingNaive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Bloo
NCT03779854
Fred Hutchinson Cancer CenterPhase 2
Active Not RecruitingHu8F4 in Treating Patients With Advanced Hematologic Malignancies
NCT02530034
M.D. Anderson Cancer CenterPhase 1
CompletedSelective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Rela
NCT02220985
Fred Hutchinson Cancer CenterPhase 2
CompletedSelective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in
NCT01858740
Fred Hutchinson Cancer CenterPhase 2
Active Not RecruitingAzacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic S
NCT01522976
National Cancer Institute (NCI)Phase 2